Feb 15, 2023 - Feb 15, 2023 8:00 to 9:30 pm EST (5:00 pm PST, 7:00 pm CT, 9:00 pm AST) Group Peer Support Events Our virtual group peer support program invites people affected by IBD to connect with and provide support to others living with or caring for someone with Crohn’s and colitis. Group sessions ... Read MoreEn savoir plus LocationEmplacement • Virtual CategoryCatégorie • Peer supportSoutien entre pairs
Feb 22, 2023 - Feb 23, 2023 7 00 pm - 8 30 pm ET Clinical Trials 101 Have you been wondering about the ins and outs of clinical trials? Join us to learn about the types of clinical trials, including those open to the IBD community in Canada. People with Crohn’s ... Read MoreEn savoir plus LocationEmplacement • Zoom (Virtual) CategoryCatégorie • EducationÉducation
Feb 28, 2023 - Feb 28, 2023 7:30 to 9:00 pm EST (4:30 pm PST, 6:30 pm CT, 8:30 pm AT) Group Peer Support Events Our virtual group peer support program invites people affected by IBD to connect with and provide support to others living with or caring for someone with Crohn’s and colitis. Group sessions ... Read MoreEn savoir plus LocationEmplacement • Virtual CategoryCatégorie • Peer supportSoutien entre pairs
Apr 24, 2023 - Apr 25, 2023 7 00 pm - 8 30 pm ET Gut Mucosal Healing and New and Emerging Therapies Are you familiar with mucosal healing in inflammatory bowel disease? Join us to hear from an expert gastroenterologist about how inflammation in Crohn's and colitis affects the intestinal (gut ... Read MoreEn savoir plus LocationEmplacement • Zoom (Virtual) CategoryCatégorie • EducationÉducation
Nov 8, 2022 The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada Learn moreEn savoir plus
Nov 7, 2022 Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients Learn moreEn savoir plus
Nov 1, 2022 November is Crohn’s & Colitis Awareness Month, and We Need Your Help Learn moreEn savoir plus
Oct 20, 2022 Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease Learn moreEn savoir plus
Oct 13, 2022 Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada Learn moreEn savoir plus